Differential Thrombogenesis by EPA and DHA Mediated by HDL
Part of paid clinical trials in Providence, Rhode Island.
- Sponsor
- The Miriam Hospital
- Study ID
- NCT06494488
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Hypertriglyceridemia
- Lipid Metabolism Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 69 Years
- Healthy Volunteers
- Not accepted
Interventions
- EPA — DRUGFish oil
- DHA — DRUGFish oil
Study Details
The goal of this study is to learn more about omega-3 polyunsaturated fatty acids supplementation on blood lipid profile and platelets in patients with high cholesterol levels. The purpose of this research is to gather information on the safety and effect of two different fish oils, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Participants will: Visit the clinic 3 times during study checkups, tests and blood collection. Randomized to either the EPA or the DHA supplementation group. Be given a 28-day food and activity log.
Key Dates
- Start date
- Jul 10, 2025
- Status verified
- Sep 2025
- Primary completion
- Aug 1, 2027
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- Experimental: DHA groupParticipants will receive DHA supplement. 3 gelcaps, three times per day with meals (breakfast, lunch, and dinner). DHA supplement regimen contains 450 mg DHA and minimal EPA (60 mg) per pill. Participants will be given 28-day food and activity log.
- Experimental: EPA groupParticipants will receive EPA supplement. 2 gelcaps, two times per day with meals (breakfast and dinner). 1 gelcap consists of 1 gram of EPA. Participants will be given 28-day food and activity log.
Primary Outcome Measure
Percentage of Platelet Aggregation Area Under the Curve (AUC) Over Time [ Time Frame: 8 weeks ]
Central Contacts
- Wenliang Song, MD4014449851
- Daria Salamevich4014449857
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brown University Health - Lipid Clinic | Providence | Rhode Island | 02914 |
Find similar trials in Providence, RI
By research site
Related Studies
- Long-Term Safety and Efficacy of Plozasiran in Adults With HypertriglyceridemiaPHASE3 · Recruiting · Arrowhead Pharmaceuticals · Bakersfield, California
- A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant CholesterolPHASE2 · Recruiting · Marea Therapeutics · Chula Vista, California
- A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory DyslipidemiasPHASE1 · Recruiting · CRISPR Therapeutics AG · Jacksonville, Florida
- A Study to Assess the Safety, Tolerability and Efficacy of ION775PHASE2 · Recruiting · Ionis Pharmaceuticals, Inc. · Lincoln, California